Table 1.
Clinical data of the patients included in the discovery cohort study.
| Sample ID | SMA type | Age at sample collection (years) | Gender | HFMS |
|---|---|---|---|---|
| SMA‐1 | 2 | 4.7 | Male | 23 |
| SMA‐2 | 2 | 8 | Male | 26 |
| SMA‐3 | 2 | 8.1 | Female | 10 |
| SMA‐4 | 2 | 9.8 | Female | 19 |
| SMA‐5 | 2 | 9.9 | Female | 4 |
| SMA‐6 | 2 | 9.9 | Female | 15 |
| SMA‐7 | 2 | 10.9 | Male | 2 |
| SMA‐8 | 2 | 15.1 | Male | NA |
| SMA‐9 | 2 | 15.2 | Male | NA |
| SMA‐10 | 2 | 16.1 | Male | NA |
| SMA‐11 | 3 | 4.7 | Female | 54 |
| SMA‐12 | 3 | 6 | Female | 26 |
| SMA‐13 | 3 | 8 | Female | 49 |
| SMA‐14 | 3 | 9.6 | Male | 31 |
| SMA‐15 | 3 | 10.5 | Female | 32 |
| SMA‐16 | 3 | 12.4 | Male | NA |
| SMA‐17 | 3 | 13 | Female | 37 |
| SMA‐18 | 3 | 13 | Female | NA |
| SMA‐19 | 3 | 13.5 | Female | NA |
| SMA‐20 | 3 | 17 | Male | NA |
Presented are the type of SMA, age at sample collection, gender and HFMS score of the patients (NA = not available). HFMS, Hammersmith Functional Motor Scale; SMA, spinal muscular atrophy.